Literature DB >> 4027145

The effect of nicardipine on blood pressure, its variability and reflex cardiac control.

W A Littler, M A Young.   

Abstract

Eight untreated patients with essential hypertension (average casual blood pressure 180/110 +/- 27/12 mm Hg) were studied following control, acute (a single oral dose of 30 mg nicardipine hydrochloride), and chronic (2 months nicardipine oral therapy) treatment periods. During the 2 month treatment period, ambulatory mean intra-arterial (IABP), measured when the patients were awake, fell from 165/105 +/- 6/12 (control) to 150/96 +/- 14/12 mm Hg (P less than 0.05), but heart rate remained unchanged (84 +/- 12 control vs 80 +/- 9 beats min-1). There was an absolute reduction in blood pressure in response to tilting, the Valsalva manoeuvre, and exercise handgrip, but the percent increase in pressure following nicardipine was not significantly different from that in the control period. There was no change in baroreflex sensitivity after either acute or chronic treatment, but the set point of the reflex was reset to a lower pressure following chronic therapy. Both single and multiple doses of nicardipine significantly reduced intra-arterial pressure. Chronic therapy was associated with return of the heart rate to control values, which was due to resetting of the baroreflex control mechanism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4027145      PMCID: PMC1400771          DOI: 10.1111/j.1365-2125.1985.tb05152.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  Characteristics of single carotid sinus baroreceptor fibers and whole nerve activity in the normotensive and the renal hypertensive dog.

Authors:  P Sleight; J L Robinson; D E Brooks; P M Rees
Journal:  Circ Res       Date:  1977-12       Impact factor: 17.367

2.  Reflex regulation of arterial pressure during sleep in man. A quantitative method of assessing baroreflex sensitivity.

Authors:  H S Smyth; P Sleight; G W Pickering
Journal:  Circ Res       Date:  1969-01       Impact factor: 17.367

3.  Continuous recording of direct arterial pressure and electrocardiogram in unrestricted man.

Authors:  W A Littler; A J Honour; P Sleight; F D Stott
Journal:  Br Med J       Date:  1972-07-08

4.  Influence of once-daily administration of beta-adrenoceptor antagonists on arterial pressure and its variability.

Authors:  R D Watson; T J Stallard; W A Littler
Journal:  Lancet       Date:  1979-06-09       Impact factor: 79.321

5.  The effect of nifedipine on arterial pressure and reflex cardiac control.

Authors:  R A McLeay; T J Stallard; R D Watson; W A Littler
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

6.  Baroreflex setting and sensitivity after acute and chronic nicardipine therapy.

Authors:  M A Young; R D Watson; W A Littler
Journal:  Clin Sci (Lond)       Date:  1984-02       Impact factor: 6.124

  6 in total
  6 in total

1.  Antihypertensive efficacy of the calcium-antagonist felodipine in patients with persisting hypertension on beta-adrenoceptor blocker therapy. The Canadian Felodipine Study Group.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

2.  Nicardipine in the treatment of essential hypertension controlled 6-month-study comparing nicardipine with propranolol at rest and during exercise.

Authors:  A Danielsson; P Bjerle; B Ek; L Steen; O Suhr
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 3.  'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.

Authors:  D D Freedman; D D Waters
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

4.  The effects of an intravenous nicardipine injection on baroreflex control of heart rate in man.

Authors:  Z Wajima; T Inoue; R Ogawa
Journal:  J Anesth       Date:  1993-01       Impact factor: 2.078

5.  Double-blind, randomized comparative study of the antihypertensive effect of nicardipine slow-release and nifedipine slow-release in hypertensive patients with coronary heart disease.

Authors:  F K Maetzel; W E Teufel; A Griebel; M H Glocke
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

Review 6.  Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.